Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
- FAPESP - São Paulo Research Foundation
- ;
- CENTD / Butantan Institute
- Center for Research and Innovation in Biodiversity and Drug Discovery
- FMUSP
- Institute of Biosciences, University of São Paulo
- National Institute of Telecommunications
- São Carlos School of Engineering, University of São Paulo
- University of Campinas (UNICAMP)
- University of Sao Paulo
-
Field
-
(the University of São Paulo's Ribeirão Preto Medical School). CRID is receiving post-doctoral applications from motivated candidates to integrate a project to develop a biopharmaceutical for the treatment
-
: Milena Soriano Marcolino (UFMG). Mandatory requirements: 1) Undergraduate degree in the Health field; 2) PhD in Health Sciences or related field; 3) Experience in participating in projects in the Health
-
of these surrogates in mouse models. Join us to expand treatment options for diabetic patients and drive advances in research areas. To register, please send the following documents to [email protected] by
-
candidate will develop a project in the research area of membrane modification for effluent treatment through photocatalysis. Candidates should have experience in the development of filtration/photocatalysis
-
computer simulations. The successful candidate will be a motivated individual, holding a PhD in structural biology or related areas and experience in protein NMR spectroscopy or MD simulations. Prior
-
-DOT (VDOT) strategy compared to Self-Administered Treatment and conventional Directly Observed Treatment in municipalities in the state of São Paulo. The candidate must have knowledge of mobile
-
. The candidate is expected to present a list of publications in relevant journals and conferences associated with at least one of the aforementioned topics, and to have a PhD degree or be close to acquiring one in
-
) strategy compared to Self-Administered Treatment and conventional Directly Observed Treatment in municipalities in the state of São Paulo. The candidate must have previous experience in research projects in
-
pluripotent stem cells exposed to the serum of diabetic patients with coronary artery disease before and after treatment with empagliflozin. Candidates with experience in cell culture, intracellular Ca2
-
identification of potential new targets for the development of innovative drugs, which enable more effective treatment of symptoms, or even their cure and/or possible prevention. The selected candidate must have a